Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Systemic Therapy Combined With Radiotherapy Versus Systemic Therapy Alone for Oligometastatic Kidney CancER (STROKER): A Multicenter, Randomized Controlled Phase III Trial

NCT06726421 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT06726421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06726421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Systemic Therapy Combined With Radiotherapy Versus Systemic Therapy Alone for Oligometastatic Kidney CancER (STROKER): A Multicenter, Randomized Controlled Phase III Trial
Lead sponsor
Sun Yat-sen University
Phase
Phase 3
Overall status
Recruiting
Start date
September 18, 2024
Completion date
September 30, 2033
Enrollment
252 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer metastatic, renal cell carcinoma (kidney cancer), renal cell carcinoma metastatic